Ward et al. (2018) proved that quercetin therapy significantly reduced the cell viability of PCa cells (LNCaP, PC-3, and DU-145) in a time- and dose-dependent manner, indicating that quercetin exerts its anti-cancer activity by regulating Akt, ROS, and NF-κB pathways (Ward et al. 2018, Hatawsh et al. 2024). This evidence concerns the gene AKT1 and cancer.